BackTable / VI / Contributor

Dr. Justin Lee

Interventional Radiologist

Dr. Justin Lee is a practicing interventional radiologist at Radiology Associates of Florida in Tampa, FL.

Listen to Dr. Justin Lee on the BackTable Podcast

The BackTable Podcast is a knowledge resource by physicians for physicians. Learn from the experiences and expertise of Dr. Justin Lee and get practical advice on how to build your practice by listening to the BackTable Podcast.

Ep 92 Interventional Oncology in Private Practice (Part 2) with Dr. Justin Lee

00:00 / 01:04

More about this episode

Stay Up To Date

Follow:

Subscribe:

Podcasts Featuring Dr. Justin Lee

VI Episode #92

Interventional Oncology in Private Practice (Part 2)

Interventional Radiologist Justin Lee tells us about his approach to treatment of Hepatocellular Carcinoma (HCC), including how this has changed over his years in private practice. This is part two of a two part series.

VI Episode #91

Interventional Oncology in Private Practice (Part 1)

Interventional Radiologist Justin Lee tells us how he started from scratch in growing a robust Interventional Oncology program in private practice, including pitfalls to avoid. This is part one of a two part series.

VI Episode #20

Pressure-Directed Therapy in TACE

Our 20th BackTable podcast episode featuring special guests Dr. Justin Lee of Florida Interventional Specialists, and Dr. Terence Gade of Hospital of University of Pennsylvania. They discuss experiences and utility of pressure-directed, antireflux infusion for TACE treatments.

Articles Featuring Dr. Justin Lee

Pressure-Directed Therapy for the Treatment of Hepatocellular Carcinoma (HCC)

Effective drug delivery systems attempt to maximize homogeneous distribution of the respective agent to the entire tumor to induce cytotoxicity and tumor necrosis. Dr. Justin Lee and Dr. Terence Gade discuss how pressure-directed therapy improves drug delivery to areas of tumor burden in cases of HCC.

DEB-TACE vs Conventional TACE in the Treatment of HCC

For the treatment of HCC, it is important to know the differences between DEB-TACE vs conventional TACE. Lipiodol-based conventional transarterial chemoembolization (cTACE) and drug-eluting bead transarterial chemoembolization (DEB-TACE) are two treatment options for intermediate-stage HCC.

TACE vs Y90 in the Treatment of Hepatocellular Carcinoma

Learn the differences between TACE vs Y90 for hepatocellular carcinoma, including patient selection, benefits, side effects, and cost factors.

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.

Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

Podcasts

Interventional Oncology in Private Practice (Part 2) with Dr. Justin Lee on the BackTable VI Podcast

Interventional Oncology in Private Practice (Part 1) with Dr. Justin Lee on the BackTable VI Podcast

Pressure-Directed Therapy in TACE with Dr. Justin Lee and Dr. Terence Gade on the BackTable VI Podcast

Multidisciplinary HCC Care: Improving the Patient Experience with Combined Clinics with Dr. Tyler Sandow, Dr. Jonathan Mizrahi, Dr. Steven Young and Deondra Bonds-Adams on the BackTable VI Podcast

Topics

Metastatic Colorectal Cancer (mCRC) Podcasts

Transarterial Chemoembolization (TACE) Podcasts

More Contributors

Dr. Aparna Baheti

Dr. Asad Baig

Dr. Michael Barraza

Dr. Christopher Beck

Dr. George Behrens

Dr. Zach Berman